Brookline Capital Acquisition Predicts electroCore FY2025 Earnings

electroCore, Inc. (NASDAQ:ECOR) – Equities researchers at Brookline Capital Acquisition issued their FY2025 earnings per share estimates for electroCore in a research report issued to clients and investors on Tuesday, February 3rd. Brookline Capital Acquisition analyst F. Ahmed forecasts that the company will earn ($1.70) per share for the year. Brookline Capital Acquisition has a “Strong-Buy” rating on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. Brookline Capital Acquisition also issued estimates for electroCore’s Q4 2025 earnings at ($0.39) EPS, Q1 2026 earnings at ($0.33) EPS, Q2 2026 earnings at ($0.12) EPS, Q3 2026 earnings at ($0.08) EPS, Q4 2026 earnings at ($0.01) EPS and FY2026 earnings at ($0.53) EPS.

ECOR has been the subject of several other research reports. HC Wainwright dropped their price target on electroCore from $25.00 to $18.00 and set a “buy” rating for the company in a research report on Monday, January 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a report on Monday, December 29th. Zacks Research lowered electroCore from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Wall Street Zen upgraded shares of electroCore from a “sell” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Brookline Cap M upgraded shares of electroCore to a “strong-buy” rating in a report on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat, electroCore has a consensus rating of “Moderate Buy” and an average target price of $22.00.

electroCore Stock Up 7.5%

ECOR stock opened at $5.45 on Friday. electroCore has a 52 week low of $4.16 and a 52 week high of $19.49. The firm has a market capitalization of $43.60 million, a P/E ratio of -3.19 and a beta of 0.48. The company has a fifty day simple moving average of $5.59 and a two-hundred day simple moving average of $5.43.

electroCore (NASDAQ:ECOR) last posted its earnings results on Wednesday, November 5th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). The business had revenue of $8.69 million during the quarter, compared to analysts’ expectations of $7.84 million. electroCore had a negative net margin of 47.46% and a negative return on equity of 447.87%.

Hedge Funds Weigh In On electroCore

A number of institutional investors have recently modified their holdings of the stock. International Assets Investment Management LLC boosted its holdings in shares of electroCore by 65.7% in the second quarter. International Assets Investment Management LLC now owns 77,020 shares of the company’s stock valued at $407,000 after purchasing an additional 30,550 shares during the period. NewEdge Advisors LLC increased its holdings in electroCore by 857.9% during the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after purchasing an additional 145,047 shares during the period. Jane Street Group LLC raised its position in electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after purchasing an additional 19,599 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of electroCore in the 1st quarter worth $153,000. Finally, Two Sigma Investments LP lifted its holdings in shares of electroCore by 20.8% in the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after buying an additional 4,231 shares during the period. 26.74% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about electroCore

Here are the key news stories impacting electroCore this week:

• Positive Sentiment: Brookline Capital Management upgraded ECOR to a “Strong-Buy” and published new estimates that point toward improving profitability — forecasting FY2026 EPS of ($0.53) and a near-breakeven Q4 2026 EPS of ($0.01), which investors may view as a catalyst for the stock. Zacks Upgrade
• Neutral Sentiment: Brookline released a detailed quarter-by-quarter EPS schedule (Q4 2025: ($0.39); Q1 2026: ($0.33); Q2 2026: ($0.12); Q3 2026: ($0.08); Q4 2026: ($0.01)) giving investors a roadmap for when improvement is expected, but these are analyst projections rather than company guidance. MarketBeat Estimates
• Negative Sentiment: Despite the upgrade, Brookline still models a sizable loss for FY2025 (forecast: ($1.70) EPS), which is worse than the current consensus full-year estimate of ($1.49) — a reminder that near-term profitability and cash flow remain risk factors. MarketBeat Estimates

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.